Samlyn Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Samlyn Capital's MRK Position: Q2 2026 in Review
Samlyn Capital reduced its Merck (MRK) stake by 22% in Q2 2026, selling an estimated $18.8M and leaving 565,755 shares worth $72.7M. The position accounts for 1.18% of the portfolio, ranked #26.
Samlyn Capital first reported a position in MRK in Q4 2013 and has held it in 22 quarters since. The position peaked at $150M in Q2 2018. 3,832 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Samlyn Capital held 565,755 shares of Merck worth $72.7M as of Q2 2026.
- Samlyn Capital sold 160,726 Merck shares in Q2 2026, an estimated $18.8M.
- Merck made up 1.18% of Samlyn Capital's portfolio in Q2 2026, its #26 holding.
- Samlyn Capital first reported a position in Merck in Q4 2013 and has held it in 22 quarters since.
- Samlyn Capital's Merck position peaked at $150M in Q2 2018.
- 3,832 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Samlyn Capital's 13F filing for Q2 2026, filed 14 Aug 2026.